Researchers found that glutamic acid induces two transcriptional repressors, StbZIP53-like2 and StERF091, which suppress polyphenol oxidase genes linked to browning. This cooperative regulatory module alleviates browning in fresh-cut potatoes.
This innovative material combines the mechanical flexibility of an organic hydrogel with exceptional microwave absorption properties. The synergy between MXene and carbon dots provides a powerful tool for managing electromagnetic pollution in wearable electronics.
Researchers have developed an electrochemical route to produce hydrogen peroxide directly from oxygen and water under ambient conditions. Single-atom electrocatalysts play a crucial role in steering oxygen reduction chemistry towards the desired two-electron pathway.
Researchers develop hemoglobin-based nanoparticles to deliver tigecycline directly to Klebsiella pneumoniae infection sites, improving survival rates and reducing bacterial burden. The novel strategy overcomes dose-limiting toxicity and enhances pharmacokinetics of the antibiotic.
The HF-REVERT trial found that CDR132L improved secondary endpoints, including LVEF and NT-proBNP, but not the primary endpoint of LVESVI. Target engagement was confirmed by decreased plasma levels of microRNA-132. The therapy was well-tolerated with no significant safety concerns.
The summit brought together endocrine leaders to identify opportunities to work closely together on increasing the visibility of endocrine health in policy decisions. Early findings from a workforce survey revealed challenges including long patient waiting times and retention concerns among early-career clinicians.
Researchers found that low-dose digoxin and digitoxin reduced worsening heart failure events in patients with mild-to-moderate heart failure and reduced ejection fraction. The treatment was generally well-tolerated and safe, offering a cheap and effective option for managing the condition.
The APOE2 gene variant is linked to exceptional longevity and reduced Alzheimer's risk, thanks to its ability to help human neurons keep their DNA intact and resist cellular senescence. This study reveals a previously underappreciated function of the gene, shifting attention away from its role in cholesterol transport.
A new international study found that genetic variations in the PAM gene can reduce the effectiveness of GLP-1 receptor medications, such as Ozempic. Researchers discovered that 44% of people with these genetic variants experienced reduced glucose lowering properties, and only 11% achieved recommended glucose levels.
The study introduces a triboelectric-driven framework that unifies visual, tactile, auditory, olfactory, and gustatory inputs within a self-powered architecture. The system demonstrates high-accuracy cross-modal recognition and adaptive sensory reconfiguration, offering a new pathway toward energy-autonomous robotic cognition.
Researchers develop a light-driven antenna-reactor photocatalyst that achieves highly efficient alkyne semihydrogenation under ambient conditions. The system promotes efficient hydrogen dissociation while steering the reaction toward selective semihydrogenation, enabling near-complete conversion with excellent selectivity.
The 'Ozempic Era' suggests a paradigm shift in understanding obesity, blaming commercial food systems rather than individual failings. Emerging medical data on GLP-1 agonists may drive policy responses to regulate ultra-processed foods.
A new study found that reducing annual working hours by 1% is linked to a small decline in obesity rates across 33 OECD countries, with the impact being stronger for men than women. Higher income levels and urbanization also showed significant correlations with lower obesity prevalence.
A pooled analysis of trials reveals semaglutide's safety and efficacy in individuals aged 65 years and older with obesity. The study found significant reductions in body weight and improvements in cardiometabolic risk factors, with a lower proportion of adverse events compared to placebo.
A new post-hoc analysis examined daily oral orforglipron treatment for obesity, with or without diabetes, in users aged 65 years and over. The study found that orforglipron significantly reduced body weight and improved blood sugar markers compared to placebo, with a similar safety profile to the overall ATTAIN clinical trial population.
A study of 65 countries found that consuming food away from home is consistently associated with obesity. Eating out is driven by sociodemographic factors such as sex, age, income, and education, and is linked to higher energy intake and body mass index.
A large-scale Nordic study found a link between PCOS and heart disease, with women at increased risk even in normal weight. The study also highlighted the importance of regular medical screenings for women with PCOS.
Research in male sheep fetuses finds that excessive prenatal progesterone exposure alters the SRD5A1 gene, crucial for processing sex hormones in brain development. The study highlights the importance of hormones in fetal development and potential links to adult disease.
In patients with symptomatic rheumatic heart disease, digoxin significantly reduced the risk of a composite of all-cause death or new-onset or worsening heart failure. The treatment had little risk of toxicity, making it a promising therapeutic option for these patients.
Treatment with digitalis glycosides reduces worsening heart failure events in HFmrEF and HFrEF patients, suggesting its use as additional therapy to reduce worsening heart failure events. The study found no significant interaction with other important study characteristics.